InVivo Therapeutics Holdings - 53 Year Dividend History | NVIVQ
Historical dividend payout and yield for InVivo Therapeutics Holdings (NVIVQ) since 1971. The current TTM dividend payout for InVivo Therapeutics Holdings (NVIVQ) as of February 12, 2024 is $0.00. The current dividend yield for InVivo Therapeutics Holdings as of February 12, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.001B |
$0.000B |
|
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
